Your Shopping Cart
By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
FDA to launch a program to promote manufacture of safer and superior external defibrillators
- Date: November 29, 2010
- Source: Admin
![Webinar All Access Pass Subscription](https://www.complianceonline.com/images/banners/webinar-subscription-main.png)
The FDA says in a news release that it will launch a program to promote manufacture of safer and superior external defibrillators. Defibrillators are used to correct heart rhythms. External defibrillators are used thousands of times a year to treat cardiac arrest. Automated external defibrillators (AEDs) are conspicuous in public places. They are even more conspicuous in homes, airports and office buildings. Complex external defibrillators are handled by health care professionals in hospitals. Almost 300,000 Americans suffer cardiac arrest each year. They may die if normal rhythm is not restored promptly. Amongst the many steps taken immediately to revive the patient is the delivery of a high-energy shock from an external defibrillator.
Poor performance of AEDs
During the past five years, more than 28,000 instances of failure of external defibrillators have been reported to the Center for Devices and Radiological Health (CDRH) of FDA. Manufacturers have recalled hundreds of thousands of the device. Many of the failures reported to CDRH can be traced to engineering design and manufacturing practices, among others. These failures which can impact patient safety can be prevented and corrected. Hence CDRH is all set to work with manufacturers, users and experts to develop the next generation of the product.
CDRH is to release a white paper explaining the steps it is initiating to enhance the safety of external defibrillators and encourage the development of safer and superior technologies in the days to come as part of its External Defibrillator Improvement Initiative.
Amongst the goals of the initiative are:
Promoting innovation of next-generation external defibrillators to enhance their safety and effectiveness
Honing the capability of industry and FDA to identify and address problems associated with the devices being marketed so safety risks can be addressed quicker and better.
Defining a premarket regulatory pathway for AEDs to promote best practices for design and testing.
The initiative will be launched with a public meeting on Dec 15-16, 2010 at the FDA headquarters. Industry and other stakeholders will thrash out ways to improve the defibrillators. Jointly with the University of Colorado’s Department of Emergency Medicine, FDA will make the AEDs more user-friendly. A multi-city pilot project will be undertaken to link AEDs with local emergency medical services so that as soon as an AED is used, an emergency rescue team can be rushed.
Source:
Compliance Trainings
![](/images/products/medium/700851.jpg)
How FDA trains its investigators to review CAPA and what should you do to prepare
By - Jeff Kasoff
On Demand Access Anytime
By - Jeff Kasoff
On Demand Access Anytime
Excel Spreadsheets; Ensuring Data Integrity and 21 CFR Part 11 Compliance
By - David Nettleton
Live September 10, 2024
By - David Nettleton
Live September 10, 2024
![](/images/products/medium/701585.jpg)
Water System Investigation "How-To's" and Example Case Studies
By - T.C Soli
On Demand Access Anytime
By - T.C Soli
On Demand Access Anytime
![](/images/products/medium/701766.jpg)
Solutions for Addressing Fungal and Bacterial Spore Outbreaks in Pharmaceutical, Biotech, and Medical Device Operations
By - Jim Polarine
On Demand Access Anytime
By - Jim Polarine
On Demand Access Anytime
Compliance Standards
Best Sellers
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
San Francisco, CA | Aug 6-7, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 18-19, 2020
-
Los Angeles, CA | Aug 20-21, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 25-26, 2020
-
Virtual Seminar | Jun 10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | Jul 6-7, 2020
-
San Francisco, CA | Oct 22-23, 2020
-
Virtual Seminar | Jul 9-10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | June 3-4, 2020
-
Miami, FL | Jul 29-31, 2020
-
Virtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
You Recently Viewed
![Loading](/images/attendeeimages/ajax-loader.gif)